Neonatal Cardiac Emergencies

Clinical Pediatric Emergency Medicine

Volumn 19, Issue 4, 2018, Pages 340-344

  Allen, Kiona Y ^a,c   Pittsenbarger, Zachary ^a   Roben, Emily ^b  

^a Department of Medicine   (United States)

^b Emergency Medicine   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

cardiac; cyanosis; emergency; neonate

Indexed keywords

PROSTAGLANDIN E1;

ARTICLE; CARDIOGENIC SHOCK; CYANOTIC HEART DISEASE; DIFFERENTIAL DIAGNOSIS; EMERGENCY CARE; EMERGENCY HEALTH SERVICE; HEART DISEASE; HEART INJURY; HUMAN; LUNG BLOOD FLOW; OUTCOME ASSESSMENT; PEDIATRIC CARDIOLOGY; SYSTEMIC CIRCULATION; SYSTEMIC OBSTRUCTIVE CARDIAC LESION;

EID: 85059933250     PISSN: 15228401     EISSN: 15582310     Source Type: Journal    
DOI: 10.1016/j.cpem.2018.12.007     Document Type: Article

References (13)

1. Van der Linde, D., Konings, E.E., Slager, M.A., et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol 58 (2011), 2241–2247.
2. Hoffman, J.I., Kaplan, S., The incidence of congenital heart disease. J Am Coll Cardiol 39 (2002), 1890–1900.
3. Chang, R.K., Gurvitz, M., Rodriguez, S., Missed diagnosis of critical congenital heart disease. Arch Pediatr Adolesc Med 162 (2008), 969–974.
4. Brooks, P.A., Penny, D.J., Management of the sick neonate with suspected heart disease. Early Hum Dev 84 (2008), 155–159.
5. Liberman, R.F., Getz, K.D., Lin, A.E., et al. Delayed diagnosis of critical congenital heart defects: trends and associated factors. Pediatrics 134 (2014), e373–e381.
6. Plana, M.N., Zamora, J., Suresh, G., et al. Pulse oximetry screening for critical congenital heart defects. Cochrane Database Syst Rev, 3, 2018, CD011912.
7. Marino, B.S., Bird, G.L., Wernovsky, G., Diagnosis and management of the newborn with suspected congenital heart disease. Clin Perinatol 28 (2001), 91–136.
8. Danford, D.A., Gutgesell, H.P., McNamara, D.G., Application of information theory to decision analysis in potentially prostaglandin-responsive neonates. J Am Coll Cardiol 8 (1986), 1125–1130.
9. Reddy, S.C., Saxena, A., Prostaglandin E1: first stage palliation in neonates with congenital cardiac defects. Indian J Pediatr 65 (1998), 211–216.
10. Lewis, A.B., Freed, M.D., Heyman, R.A., et al. Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease. Circulation 64 (1981), 893–898.
11. Costello, J.M., Mazwi, M.L., McBride, M.E., et al. Critical care for paediatric patients with heart failure. Cardiol Young 25 (2015), 74–86.
12. Tabbutt, S., Marino, B.S., Cardiopulmonary resuscitation in congenital and acquired heart disease. Pediatr Crit Care Med 17 (2016), S194–S200.
13. Marino, B.S., Tabbutt, S., MacLaren, G., et al. Cardiopulmonary resuscitation in infants and children with cardiac disease: a scientific statement from the American Heart Association. Circulation 137 (2018), e691–e782.